Jeanny Sui Sum Cheung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeanny Sui Sum Cheung has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Ankie Tan Cheung
The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong SAR, China
2 shared publications - Shuk Yan Mak
Paediatric Haematology and Oncology Centre, Department of Paediatrics and Adolescent Medicine, Hong Kong Children’s Hospital, Hong Kong SAR, China
2 shared publications - William Ho Cheung Li
The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong SAR, China
2 shared publications
Latest Publications
- Open Access
Sleep Disturbances and Health-Related Quality of Life in Paediatric Oncology: A Comparative Study with Non-Oncological Chronic Illness and Healthy Peers
Background/Objectives: Sleep disturbance is increasingly recognized as a key contributor to symptom burden and functioning in paediatric oncology, yet comparative evidence across clinical and healthy populations remains limited. This study examined sleep quality and its association with health-related quality of life (HRQoL) in children and adolescents with cancer compared with peers with non-oncological chronic illnesses and healthy controls. Methods: A cross-sectional study was conducted at Hong Kong Children’s Hospital. Participants 6–18 years were recruited by convenience sampling into three groups (oncology, chronic illness, healthy; n = 50 each). Children and adolescents completed the Chinese Pittsburgh Sleep Quality Index (PSQI) and Pediatrics Quality of Life Inventory (PedsQL) 4.0. Group differences were tested using chi-square tests and one-way analysis of variance (ANOVA) with post hoc Tukey comparisons. Pearson correlations and hierarchical multiple linear regression examined PSQI-PedsQL associations. Results: Sleep quality differed significantly across groups (p < 0.001), with the poorest sleep observed in the oncology group. The prevalence of poor sleep (PSQI ≥ 5) was 60.0% in oncology group, compared with 40.0% in those with chronic illness and 30.0% in healthy peers. Mean global PSQI scores were 6.02 ± 3.40 in the oncology group, 4.10 ± 2.60 in the chronic illness group, and 3.30 ± 2.35 in healthy controls, with a significant overall group difference (p < 0.001). Impairments were most pronounced in sleep latency, habitual sleep efficiency, and sleep disturbances. HRQoL was lowest in the oncology group (p < 0.001). Mean PedsQL total scores were 68.98 ± 15.73 in the oncology group, 75.99 ± 14.03 in the chronic illness group, and 85.44 ± 10.26 in healthy controls, respectively, with a significant overall group difference (p < 0.001). Across the full sample, poor sleep quality was independently associated with lower HRQoL after adjustment for demographic and clinical factors (β = −0.271, p = 0.002), with no significant interaction by group. Conclusions: Children and adolescents with cancer reported clinically significant sleep impairment, driven mainly by reduced sleep quality and continuity. Routine sleep screening and targeted supportive interventions may improve HRQoL in paediatric oncology.
Open AccessSleep Disturbances and Health-Related Quality of Life in Paediatric Oncology: A Comparative Study with Non-Oncological Chronic Illness and Healthy Peers
Background/Objectives: Sleep disturbance is increasingly recognized as a key contributor to symptom burden and functioning in paediatric oncology, yet comparative evidence across clinical and healthy populations remains limited. This study examined sleep quality and its association with health-related quality of life (HRQoL) in children and adolescents with cancer compared with peers with non-oncological chronic illnesses and healthy controls. Methods: A cross-sectional study was conducted at Hong Kong Children’s Hospital. Participants 6–18 years were recruited by convenience sampling into three groups (oncology, chronic illness, healthy; n = 50 each). Children and adolescents completed the Chinese Pittsburgh Sleep Quality Index (PSQI) and Pediatrics Quality of Life Inventory (PedsQL) 4.0. Group differences were tested using chi-square tests and one-way analysis of variance (ANOVA) with post hoc Tukey comparisons. Pearson correlations and hierarchical multiple linear regression examined PSQI-PedsQL associations. Results: Sleep quality differed significantly across groups (p < 0.001), with the poorest sleep observed in the oncology group. The prevalence of poor sleep (PSQI ≥ 5) was 60.0% in oncology group, compared with 40.0% in those with chronic illness and 30.0% in healthy peers. Mean global PSQI scores were 6.02 ± 3.40 in the oncology group, 4.10 ± 2.60 in the chronic illness group, and 3.30 ± 2.35 in healthy controls, with a significant overall group difference (p < 0.001). Impairments were most pronounced in sleep latency, habitual sleep efficiency, and sleep disturbances. HRQoL was lowest in the oncology group (p < 0.001). Mean PedsQL total scores were 68.98 ± 15.73 in the oncology group, 75.99 ± 14.03 in the chronic illness group, and 85.44 ± 10.26 in healthy controls, respectively, with a significant overall group difference (p < 0.001). Across the full sample, poor sleep quality was independently associated with lower HRQoL after adjustment for demographic and clinical factors (β = −0.271, p = 0.002), with no significant interaction by group. Conclusions: Children and adolescents with cancer reported clinically significant sleep impairment, driven mainly by reduced sleep quality and continuity. Routine sleep screening and targeted supportive interventions may improve HRQoL in paediatric oncology.
- Open Access
- 15 July 2026
- Published by MDPI AG in Preprints.org
Sleep Disturbances and Health-Related Quality of Life in Paediatric Oncology: A Comparative Study with Chronic Illness and Healthy Peers
Background/Objectives: Sleep disturbance is increasingly recognized as a key contributor to symptom burden and functioning in paediatric oncology, yet comparative evidence across clinical and healthy populations remains limited. This study examined sleep quality and its association with HRQoL in children with cancer compared with peers with other chronic illnesses and healthy controls. Methods: A cross-sectional study was conducted at HKCH. Participants 6-18 years were recruited by convenience sampling into three groups (oncology, chronic illness, healthy; n=50 each). Children completed the Chinese PSQI and PedsQL 4.0. Group differences were tested using chi-square tests and one-way ANOVA with post-hoc Tukey comparisons. Pearson correlations and hierarchical multiple linear regression examined PSQI-PedsQL associations. Results: Sleep quality differed significantly across groups (p<0.001), with the poorest sleep observed in the oncology group. The prevalence of poor sleep (PSQI≥5) was 60.0% in children with cancer, compared with 40.0% in those with chronic illness and 30.0% in healthy peers. Impairments were most pronounced in sleep latency, habitual sleep efficiency, and sleep disturbances. HRQoL was lowest in the oncology group (p<0.001). Across the full sample, poor sleep quality independently predicted lower HRQoL after adjustment for demographic and clinical factors (β=−0.271, p=0.002), with no significant interaction by group. Conclusions: Children with cancer reported clinically significant sleep impairment, driven mainly by reduced sleep quality and continuity. Routine sleep screening and targeted supportive interventions may improve HRQoL in paediatric oncology.
- 15 July 2026
- Published by MDPI AG in Preprints.org
Open AccessSleep Disturbances and Health-Related Quality of Life in Paediatric Oncology: A Comparative Study with Chronic Illness and Healthy Peers
Background/Objectives: Sleep disturbance is increasingly recognized as a key contributor to symptom burden and functioning in paediatric oncology, yet comparative evidence across clinical and healthy populations remains limited. This study examined sleep quality and its association with HRQoL in children with cancer compared with peers with other chronic illnesses and healthy controls. Methods: A cross-sectional study was conducted at HKCH. Participants 6-18 years were recruited by convenience sampling into three groups (oncology, chronic illness, healthy; n=50 each). Children completed the Chinese PSQI and PedsQL 4.0. Group differences were tested using chi-square tests and one-way ANOVA with post-hoc Tukey comparisons. Pearson correlations and hierarchical multiple linear regression examined PSQI-PedsQL associations. Results: Sleep quality differed significantly across groups (p<0.001), with the poorest sleep observed in the oncology group. The prevalence of poor sleep (PSQI≥5) was 60.0% in children with cancer, compared with 40.0% in those with chronic illness and 30.0% in healthy peers. Impairments were most pronounced in sleep latency, habitual sleep efficiency, and sleep disturbances. HRQoL was lowest in the oncology group (p<0.001). Across the full sample, poor sleep quality independently predicted lower HRQoL after adjustment for demographic and clinical factors (β=−0.271, p=0.002), with no significant interaction by group. Conclusions: Children with cancer reported clinically significant sleep impairment, driven mainly by reduced sleep quality and continuity. Routine sleep screening and targeted supportive interventions may improve HRQoL in paediatric oncology.